Bill119th CongressFiled Apr 16, 2026Health
H.R. 8339
Drug Origin Transparency Act of 2026
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it does
A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.
What just happenedApr 16, 2026
Referred to the House Committee on Energy and Commerce.
Who’s behind it
Rep. Matsui, Doris O. [D-CA-7](D-CA)Sponsor
3 cosponsors1 D2 R
3cosponsors1committees3actions
- Introduced in HouseApr 16, 2026
- Apr 16, 2026IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
- Apr 16, 2026IntroReferralIntro-H
Introduced in House
- Apr 16, 2026IntroReferral1000
Introduced in House